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Abstract
Microarray technology, originally developed for highly parallel examination of gene expression is regarded as a potential tool in prognosis and
diagnosis. With respect to a discrimination analysis, difference as small as one nucleotide base can be distinguished using oligonucleotide-based
microarrays. However, this degree of specificity is dependent on several parameters, including the size of the oligoprobes and the sequence context
of the probes (e.g. local melting temperature), hybridization conditions and to some extent the chemistry of the glass slides onto which the probes
are deposited. Using bovine respiratory syncytial virus (BRSV) as a model study, an oligonucleotide-based microarray approach was developed to
measure the relative abundance of a particular single nucleotide variant within mixed BRSV populations. Using this technology, we show that it
is possible to discriminate at a rate of 1%, minority variants in a BRSV population.

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1. Introduction
Human and bovine respiratory syncytial viruses (HRSV and
BRSV) are closely related paramyxoviruses responsible for
severe lower respiratory tract disease in infants and calves,
respectively. The bronchiolitis and pneumonia caused by BRSV
in calves are similar clinically, pathologically, and epidemiolog-
ically to the disease caused by HRSV in children.
Because of the high mutation rate operating during RNA
genome replication, BRSV populations are genetically hetero-
geneous (Deplanche et al., 2007) and exhibit an important
potential for variationwhich is reflected in its antigenic diversity.
Despite evidence of the highly heterogeneous nature of RNA
viral populations, the consensus sequence is often the unique
criteria used to characterize these genome populations. Work
with different viral systems has highlighted the significance of
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the mutant spectrum – the distribution of variants continuously
generated during the error-prone replication of RNA genomes –
for the study of RNA viral quasispecies and their adaptability to
changing environments (Domingo et al., 2006). Analysis of the
mutant spectrum can also provide valuable information on virus
response to antiviral treatments (Domingo and Gomez, 2007),
and may find applications for the quality control of attenuated
vaccines, including the risk associated with virulence reversion
(Amexis et al., 2001). This calls for methods capable of deter-
mining distributions of mutations within RNA virus genome
populations that should be rapid and cost-effective, but prefer-
entially high throughput. Sequencing of a viral genomic region
from a collection of biological clones (virus from individual
plaques formed on cell monolayers) and/or molecular clones
(RT-PCR products cloned in E. coli) is a common method to
generate coarse-grained pictures of the mutant spectrum. Alter-
natively, Q-PCR assays have been developed to determine the
frequency of particular mutant genomes within viral popula-
tions. Recently, a number of Q-PCR-derived methods have been
developed for the assessment of genetic stability and quantitative
monitoring of genetic changes inRNAviruses of clinical interest
(WoodandMacadam, 1997;Amexis et al., 2001). TheMAPREC
method,which combinesQ-PCR to enzyme restriction cleavage,
has proven to be a sensitive method (Chumakov et al., 1992),
yet is restricted to a limited number of known mutations (Wood
and Macadam, 1997). Amexis et al. (2001) proposed to com-
bine MAPREC with matrix-assisted laser desorption/ionization
time-of-flight (MALDI-TOF) mass spectrometry (DNA Mas-
sArray). However, major disadvantages of these methods are
that they are comparatively labour intensive, low throughput
and expensive.
We have recently shown that single nucleotide changes can
be distinguished using oligonucleotide-based microarrays (Le
Berre et al., 2003), suggesting that monitoring of genetic hetero-
geneity within viral quasispecies could be achieved using DNA
microarrays. This technique permits simultaneous interrogation
with a large number of probe sequences with high robustness
and at a lower price per assay. The degree of specificity can
be influenced by different parameters, including the size of the
oligoprobes or their sequence context (e.g. local melting temper-
ature), hybridization conditions and to some extent the chemistry
of the glass slides onto which the probes are deposited. The liter-
ature is relatively vaguewith respect to these technical questions,
as for instance probe sizes from 13 up to 50mers have been used
to diagnose various viral species (Warsen et al., 2004; Ryabinin
et al., 2006; Martin et al., 2006; Palacios et al., 2007).
UsingBRSVas amodel study,we investigated optimal condi-
tions to discriminate between parental andmutants of BSRV at a
specific genome position using DNA oligo-microarrays. Using
this technology, we show that it is possible to discriminate at
a rate of 1%, single nucleotide minority variants in a BRSV
population.
2. Materials and methods
2.1. Virus populations
BRSV populations W2BT10 and W2HEp58 derived from
strain W2-00131 (Deplanche et al., 2007). Virus population
W2BT10 was obtained upon propagation of BRSV W2-00131
in bovine turbinate (BT; ATCC reference CRL1390) cells for
10 passages. BRSV W2HEp58 was derived from population
W2BT10 following virus amplification in baby hamster kid-
ney 21 (BHK-21; ATCC reference CCL-10) cells and long-term
propagation (58 passages) in human epithelial 2 (HEp-2; ATCC
reference CCL-23) cells.
2.2. Oligonucleotides design
Two sets of oligonucleotides specific to BRSV genomic
region encoding phosphoprotein P (GeneBank accession no.
AF092942) were designed (Table 1). The probe lengths of the
first set was 14–15 mers and a second set from 19–23. Unless
otherwise stated, these probes were flanked with a 15 mer poly
dT at their 5′-extremity. The single nucleotide that discrimi-
nates between BRSV parental (W2BT10) and the BRSVmutant
(W2HEp58) genomes (position 2686 on the RNA genome) was
always positioned at the centre of the 14–22 mers oligonu-
Table 1
Oligonucleotides specific to BRSV genome
Oligonucleotide Sequence (5′→3′)a Genomic
positionb
P112-1 TTCTTCATTATTGT 2692–2679
P112-2 TTCTTCCTTATTGT 2692–2679
P112-3 CAATAATGAAGAAG 2680–2693
P112-4 CAATAAGGAAGAAG 2680–2693
P112-5 ACAATAATGAAGAAG 2679–2693
P112-6 ACAATAAGGAAGAAG 2679–2693
P112-7 TTCTTCATTATTGTC 2692–2678
P112-8 TTCTTCCTTATTGTC 2692–2678
P112-9 CAATAATGAAGAAGA 2680–2694
P112-10 CAATAAGGAAGAAGA 2680–2694
P112-19 wt TGACAATAATGAAGAAGAA 2677–2695
P112-19 mut TGACAATAAGGAAGAAGAA 2677–2695
P112-21 wt TTGACAATAATGAAGAAGAAT 2676–2696
P112-21 mut TTGACAATAAGGAAGAAGAAT 2676–2696
P112-23 wt TTTGACAATAATGAAGAAGAATC 2675–2697
P112-23 mut TTTGACAATAAGGAAGAAGAATC 2675–2697
F70-23 AATGTGTGTAAAAGTACTGATTC 5768–5790
F218-19 CCAACATAGTAACTGTGAT 6213–6231
a The mutated position is underlined.
b The numbering corresponds to the reference sequence of BRSV genome
(GeneBank accession no. AF092942).
cleotides (not taking into account the flanking spacer). Two
additional BRSV-specific oligonucleotides (F70-23 and F218-
19) mapping outside of phosphoprotein P coding region were
used as a control. The oligonucleotides were purchased from
Operon.
2.3. Preparation of target DNA
Target DNA was obtained by PCR amplification from plas-
midDNAor cDNA templates using labelled oligonucleotides 5′-
Cy5-GGAAACTATAGAAACATTTGACAATAA-3′ (BRSV
genome position 2659–2685) and 5′-Cy5-ATATGAGTAGCT-
TGATTCTTCTTC-3′ (BRSV genome position 2710–2687).
cDNA templates were produced by retrotranscription (RT) of
BRSV genomic RNA using oligonucleotide N2.1 as described
by Valarcher et al. (1999). To construct plasmid DNA templates
encoding BRSV sequences derived from W2BT10 (parental)
and W2HEp58 (mutant) populations, BRSV genomic region
spanning nucleotides 1959–3333 was amplified by RT-PCR
using oligonucleotides 5′-TGGTCATGCCAGCGTACAAGC-
3′ and 5′-CATAGGAACCCATATTGTRAGAGATGC-3′ and
cloned into pCRII-TOPO vector (Invitrogen). Plasmid DNA
construction was verified by nucleotide sequencing of the PCR-
amplified BRSV fragments. Heterogeneous target DNA
samples were produced by PCR amplification using different
ratios of parental and mutant BRSV cDNAs as DNA templates
(Table 2). A SYBR green-based Q-PCR assay was used to
standardize BRSV cDNA templates derived from populations
W2BT10 (parental) and W2HEp58 (mutant). Oligonucleotides
5′-ATTCGTACATTTTGGCATTGCTC-3′ and 5′-TTCCTTC-
WACCCTACTACCTCCTCT-3′ were designed to amplify a
59 bp product from BRSV cDNA (BRSV genome position
1809–1867) using Primer Express v2.0 software (Applied
Table 2
Parental and mutant BRSV cDNAs ratios in heterogeneous target DNA samples
Heterogeneous sample cDNAs ratioa
100 100:0
99 99:1
90 93:7
50 60:40
10 15:85
1 1:99
0 0:100
a [BRSV WT cDNA]/[BRSV mutant cDNA].
Biosystems). The reaction was carried out using the qPCR
ROX-&GO Green reaction mix (QBIOgene). Thermal cycling
was performed with the GeneAmp 5700 (Applied Biosystems)
under the following conditions: 95 ◦C for 15min followed
by 40 cycles of 94 ◦C for 15 s and 59 ◦C for 30 s. Standard
curves were generated from 10-fold dilutions of plasmid DNA
template encoding parental BRSV sequence.
2.4. Microarray printing
Lyophylised oligonucleotides were dissolved in the
NexterionTM Spot solution fromSchott—0.005%SDS (20M).
They were printed on epoxy-silane-derivatized glass slides
Fig. 1. Scheme of probes spotting on epoxy-activated glass slides. Oligonu-
cleotides were spotted in quadruplicate, with a centre to centre distance of
250m. A Cy3-labelled yeast HSP12 oligonucleotide (5′-Cy3-GACACGAC-
CGGAAACATATT-3′) was spotted in quadruplicate at the right side of square
to allow anchoring of the feature for image capture by the GenePix6.0 software.
This pattern was repeated 12 times to fit with the 16 well-superstructure seal
strips from Schott Nexterion used in the hybridization step.
Fig. 2. Hybridization patterns of BRSV parental (A) and mutant (B) target DNA on the oligonucleotides arrays. The Cy5-labelled targets were produced by RT-PCR
on a BRSV genomic region encompassing position 2686. These amplicons were hybridized at 37 ◦C for 4 h. Images were captured by the laser scanner Genepix
4000A at a PMT of 600 at 635 nm and 450 at 532 nm.
(Nexterion® HiSens E fromSchott) bymechanical spottingwith
a robot (Q-Arraymini fromGenetix). Further technical informa-
tion relating to this robot can be found at P.O. Brown’s website
(http://cmgm.stanford.edu/pbrown/mguide/index.html). The
print head on the arrayer uses ‘quill’ pins SMP3 from Arraylt,
whose contact on the surface delivers about 1 nl of DNA
solution per spot, with a size diameter of about 100m under
this condition. Oligoprobes were spotted in quadruplicate,
with a centre to centre distance of 250m. An anchoring
Cy3-labelled oligonucleotide derived from yeast HSP12 gene
(5′-Cy3-GACACGACCGGAAACATATT-3′) was spotted in
quadruplicate, on the right side of the probes according to
Fig. 1. Twelve replicates of this grid were spotted on the slide.
The oligo-microarrays were kept in a plastic container and
stored in a desiccator at room temperature until use.
2.5. Hybridization and scanning
Pre-hybridization of the printing area was carried out by
immersing array in ProntoTM Universal Pre-hybridization Solu-
tion (Corning) for 30min at 37 ◦C. The slides were then
transferred to a fresh container and wash for 2min with a 0.2×
SSC solution, then transferred to another container and wash for
2min with 0.1× SSC, then dried by centrifugation. Hybridiza-
tion was carried out at 37 ◦C or 55 ◦C for 2 h or 4 h in the
Eppendorf® ThermoStat Plus equipped with exchangeable ther-
moblock for four slides. A silicon joint was stick on the slide to
delimit the 12 zones of hybridization (Fig. 1). A 3l solution
of PCR target was mixed with 40l of ProntoTM short oligohy-
bridization solution (Corning) and with 3l of sonicated DNA
salmon sperm. After denaturation at 95 ◦C for 5min, the mix
was transferred onto the delimited zone of the printed slide.
Post-hybridization washes were carried out by incubating the
slides under agitation, 5min in a 2× SSC/0.1% SDS solution,
followed by 2min in a 0.2× SSC solution, then 2min into 0.1×
SSC solution. The slide was then dried by centrifugation. Flu-
orescence signals were detected by a laser scanner (GenePix
4000A from Axon Instrument) and analysed with the GenePix
6.01 software.
3. Results
3.1. Probe length is a key factor for microarray detection of
single nucleotide variations in BRSV genome
To reveal the presence of single nucleotide variants in
BRSV genome populations by oligonucleotide-based microar-
rays, target DNAs were amplified from BRSV phosphoprotein
P genomic region cloned into E. coli plasmids. Phosphopro-
tein P sequences were derived from two BRSV populations
(W2BT10 and W2HEp58), which are characterized by a T/G
polymorphism at genome position 2686.
A first set of oligonucleotide probes ranging from 14 to 17
mers were designed with the discriminating nucleotide posi-
tioned at the centre of the probe (Table 1) and printed on
epoxy-activated glass slides. This short oligonucleotide strat-
egy was chosen in accordance with a recent report showing
the detection of antigenic variants of foot-and-mouth disease
virus (FMDV) using 15-mers oligoprobes with oligo (dT)15
spacer (Martin et al., 2006). Hybridization with Cy5-labelled
target DNA with these short oligoprobes was not specific,
and neither addition of a poly dT spacer at oligonucleotide
5′ extremity, nor elevation of the hybridization temperature
(65 ◦C) could improve the signal intensity and the specificity
of the hybridization on the parental DNA target. Therefore,
these experiments were repeated using longer oligonucleotides
from 19 to 23 mer spotted on Nexterion® HiSens E (Schott)
slide. In these conditions, 2 h hybridization at 37 ◦C was suf-
ficient to obtain an intense fluorescence signal at each spot,
although the absolute intensity was dependent upon the length
of the oligonucleotide probes, with a maximal hybridization
signal on the 23 mer probes (Fig. 2). However, discrimina-
tion between T2686 and G2686 target DNAs, as determined by
the T/G signal ratio, was optimal with the 19 mer oligoprobes
(Fig. 3). The T/G signal ratio was not enhanced by using purified
target DNA (PCR products), whereas target signal intensities
were strongly reduced after the purification procedure, proba-
bly as a result of the loss of labelled material. As expected, no
hybridization was observed between Cy5-labelled target DNA
and oligoprobes designed on the F70 and F218 BRSV genomic
regions, as they mapped outside of the phosphoprotein P coding
region.
Fig. 3. Influence of the probe sizes on the hybridization specificity of BRSV
parental and mutant genome. The target BRSV wild type (A) and BRSV mutant
(B) were produced as in Fig. 2. They were hybridized at 37 ◦C for 4 h and the
specificity was expressed as the ratio of the BRSV parental hybridization signal
vs. that of the mutant on each oligoprobe.
Fig. 4. Discrimination rate of BRSV parental cDNA vs. BRSV mutant cDNA. The Cy5-labelled targets from BRSV parental and mutant genome were produced by
RT-PCR as in Fig. 2. The parental and mutant amplicons were mixed at various ratios as indicated in Table 2, and were hybridized on a 21 mer oligoprobes at 55 ◦C
for 2 h. (B) Corresponds to a zoom of the histogram (A) for heterogeneous samples 10, 1 and 0. The fluorescent signals were captured using laser scanner Axon
GenePix 4000A with a PMT of 600 at 635 nm and 450 at 532 nm. The discrimination was expressed as the ratio of hybridization signal between BRSV parental and
mutant genome.
3.2. Sensitivity limit for discrimination of mutant variants
within BRSV populations
Data given above showed that the parental and the mutant
BRSV genome at position 2686 could be discriminated using
19 or 21 mer oligonucleotides. The discriminative sensitivity
was quantified by mixing different proportions of parental and
mutant cDNA before performing a labelled PCR on this pre-
pared mix (Table 2). These PCR mixtures were subsequently
hybridized to a microchip made of 21-mer oligonucleotides. As
shown in Fig. 4, a proportion of as low as 1% of the parental
amplicon in the total BRSV amplicon population gave a sta-
tistically significant, elevated fluorescent signal in comparison
to residual fluorescent signal obtained with a population made
of 100% of the mutant amplicon. This discrimination rate was
around 10 times higher than the one reported by Proudnikov et
al. (2000) for the population of oral poliovirus vaccine, probably
because these authors used a generic microchips consisting in
all possible hexamers flanked at both ends of an octanucleotide
for detection of the neurovirulent mutants in oral poliovirus
vaccine. The discrimination rate between two different tar-
gets DNA hybridizing the same probes was also comparable
to that of a same target hybridizing two oligoprobes that dif-
fered from each other by a single point mutation (Le Berre et
al., 2003).
4. Discussion
Recent progress in pathogen genomics and microarray tech-
nology has allowed the development of high throughput tools
for the rapid and accurate detection of human, animal and plant
pathogens. Volokhov et al. (2002) used oligonucleotidemicroar-
rays for the detection and discrimination of six species among
the Listeria genus based on sequence differences in the iap
gene. Microarrays bearing 40–70 mer oligonucleotides were
also designed for the genotyping of human and plant viral
pathogens (Wang et al., 2002; Bystricka et al., 2005). More
recently, Palacios et al. (2007) reported the development of a
panmicrobial microarray (GreeneChipPm) consisting of 60-mer
oligonucleotides probes for diagnosis of a large collection of
pathogens.
In all cases, these microarrays were designed for the detec-
tion of various microbes or species and the specificity was
based on the oligoprobes design. Nevertheless, the current liter-
ature reveals few quantitative DNA microarray-based analyses
of mutant genome distributions within viral populations. This
question has been addressed in this present case study aiming at
quantifying the heterogeneity of RNA genomes in viral popula-
tions. The strategy that used short 21 mer oligonucleotides was
found to be effective, because the discrimination rate between
the two genomes was around 1%. This resolution was in the
same order of magnitude as a classical RT-PCR and the recently
developed MAPREC technique.
Taken together, these results should encourage future devel-
opment for more complex oligonucleotide arrays to investigate
the genetic variability within viral population in a high through-
put manner, and to use them for the screening of viral isolates
from various sources, including healthy carriers, animals and
plants.
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